Literature DB >> 7729041

Multiple mechanisms account for genomic instability and molecular mutation in neoplastic transformation.

W B Coleman1, G J Tsongalis.   

Abstract

Neoplastic cells typically possess numerous genomic mutations and chromosomal aberrations, including point mutations, gene amplifications and deletions, and replication errors. Acquisition of such genomic instability may represent an early step in the process of carcinogenesis. Proteins involved in DNA replication, DNA repair, cell cycle progression, and others are all components of complex overlapping biochemical pathways that function to maintain cellular homeostasis. Therefore, mutational alteration of genes encoding proteins involved in these cellular processes could contribute to genomic instability. Loss of normal cellular mechanisms that guard against genomic mutation and the ensuing genomic instability might lead to accumulation of multiple stable mutations in the genome of affected cells, perhaps resulting in neoplastic transformation when some critical number of transformation-related target genes become damaged. Thus, interactions of fundamental cellular processes play significant roles in sustaining cellular normality, and alteration of any of these homeostatic processes could entrain cells to the progressive genomic instability and phenotypic evolution characteristic of carcinogenesis. Here, we discuss possible molecular mechanisms governing DNA mutation and genomic instability in genetically normal cells that might account for the acquisition of genomic instability in somatic cells, leading to the development of neoplasia. These include (a) molecular alteration of genes encoding DNA repair enzymes, (b) molecular alteration of genes responsible for cell-cycle control mechanisms, and (c) direct molecular alteration of dominantly transforming cellular protooncogenes. We also discuss normal cellular processes involved with DNA replication and repair that can contribute to the mutational alteration of critical genes: e.g., slow repair of damaged DNA in specific genes, and the timing of normal gene-specific replication.

Entities:  

Mesh:

Year:  1995        PMID: 7729041

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  13 in total

Review 1.  Neutrophils: key mediators of tumour angiogenesis.

Authors:  Simon Tazzyman; Claire E Lewis; Craig Murdoch
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

Review 2.  Oncogenes and tumor-suppressor genes in mesothelioma--a synopsis.

Authors:  J F Lechner; J Tesfaigzi; B I Gerwin
Journal:  Environ Health Perspect       Date:  1997-09       Impact factor: 9.031

3.  S-adenosylmethionine regulates apurinic/apyrimidinic endonuclease 1 stability: implication in hepatocarcinogenesis.

Authors:  Maria Lauda Tomasi; Ainhoa Iglesias-Ara; Heping Yang; Komal Ramani; Francesco Feo; Maria Rosa Pascale; M Luz Martínez-Chantar; José M Mato; Shelly C Lu
Journal:  Gastroenterology       Date:  2008-09-25       Impact factor: 22.682

4.  Evidence of genetic instability in tumors and normal nearby tissues.

Authors:  Giuseppe Geraci; Ida D'Elia; Rosanna del Gaudio; Rossella Di Giaimo
Journal:  PLoS One       Date:  2010-02-23       Impact factor: 3.240

Review 5.  S-adenosylmethionine in liver health, injury, and cancer.

Authors:  Shelly C Lu; José M Mato
Journal:  Physiol Rev       Date:  2012-10       Impact factor: 37.312

6.  An examination of radiation hormesis mechanisms using a multistage carcinogenesis model.

Authors:  H Schöllnberger; R D Stewart; R E J Mitchel; W Hofmann
Journal:  Nonlinearity Biol Toxicol Med       Date:  2004-10

7.  Combined immunodeficiency caused by a loss-of-function mutation in DNA polymerase delta 1.

Authors:  Ye Cui; Sevgi Keles; Louis-Marie Charbonnier; Amélie M Julé; Lauren Henderson; Seyma Celikbilek Celik; Ismail Reisli; Chen Shen; Wen Jun Xie; Klaus Schmitz-Abe; Hao Wu; Talal A Chatila
Journal:  J Allergy Clin Immunol       Date:  2019-10-16       Impact factor: 10.793

Review 8.  APOBEC and Cancer Viroimmunotherapy: Thinking the Unthinkable.

Authors:  Richard G Vile; Alan Melcher; Hardev Pandha; Kevin J Harrington; Jose S Pulido
Journal:  Clin Cancer Res       Date:  2021-02-08       Impact factor: 12.531

9.  Epstein-Barr virus DNase (BGLF5) induces genomic instability in human epithelial cells.

Authors:  Chung-Chun Wu; Ming-Tsan Liu; Yu-Ting Chang; Chih-Yeu Fang; Sheng-Ping Chou; Hsin-Wei Liao; Kuan-Lin Kuo; Shih-Lung Hsu; Yi-Ren Chen; Pei-Wen Wang; Yu-Lian Chen; Hsin-Ying Chuang; Chia-Huei Lee; Ming Chen; Wun-Shaing Wayne Chang; Jen-Yang Chen
Journal:  Nucleic Acids Res       Date:  2009-12-23       Impact factor: 16.971

10.  In vivo targeting of ADAM9 gene expression using lentivirus-delivered shRNA suppresses prostate cancer growth by regulating REG4 dependent cell cycle progression.

Authors:  Che-Ming Liu; Chia-Ling Hsieh; Yun-Chi He; Sen-Jei Lo; Ji-An Liang; Teng-Fu Hsieh; Sajni Josson; Leland W K Chung; Mien-Chie Hung; Shian-Ying Sung
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.